{"disease":{"id":"ovary-cancer","name":"ovary cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02997553","title":"Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":744,"lead_sponsor_name":"Institut de Cancérologie de Lorraine","has_results":false},{"nct_id":"NCT07068464","title":"ICRA Randomised Controlled Trial","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":682,"lead_sponsor_name":"NHS Grampian","has_results":false},{"nct_id":"NCT04000880","title":"Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":603,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":false},{"nct_id":"NCT06331130","title":"Mesenteric Infiltration in Ovarian Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":510,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT05256576","title":"KORE-INNOVATION: a Prospective, Multi-site Clinical Trial to Implement and Analyse the Effects of an Innovative Perioperative Care Pathway to Reduce Complications for Patients with Ovarian Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":465,"lead_sponsor_name":"Charite University, Berlin, Germany","has_results":false},{"nct_id":"NCT07213193","title":"No-Stoma Policy in Advanced Ovarian Cancer Surgery","phase":"NA","overall_status":"RECRUITING","enrollment_count":395,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT06969833","title":"Prospective Clinico-biological Database of Patients With Ovarian and/or Peritoneal and/or Fallopian Tube Carcinoma","phase":"NA","overall_status":"RECRUITING","enrollment_count":371,"lead_sponsor_name":"Centre Oscar Lambret","has_results":false},{"nct_id":"NCT03842982","title":"Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer (CHIPPI)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":362,"lead_sponsor_name":"Centre Oscar Lambret","has_results":false},{"nct_id":"NCT04534075","title":"Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized Trial","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":354,"lead_sponsor_name":"Sahlgrenska University Hospital","has_results":false},{"nct_id":"NCT04532645","title":"Olaparib Real-world Utilization and Clinical Outcomes in France, Italy, and the UK","phase":"","overall_status":"COMPLETED","enrollment_count":342,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT04438564","title":"Immunoassay and Regulation of Traditional Chinese Medicine on Cancer Patients","phase":"NA","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"China Medical University Hospital","has_results":false},{"nct_id":"NCT05763511","title":"Improved Diagnosis of Ovarian Cancer by Use of Circulating Tumor DNA as a Biomarker","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT05796973","title":"Measuring Oncological Value of Exercise and Statin","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":240,"lead_sponsor_name":"Tampere University Hospital","has_results":false},{"nct_id":"NCT05677048","title":"Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":205,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT06274541","title":"Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer (HGSEC): The t-BRCA Study","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Cancer Trials Ireland","has_results":false},{"nct_id":"NCT06556342","title":"The Efficacy and Safety of FRD001 in Ultrasound Contrast Imaging for Malignant Ovarian Masses in Women","phase":"NA","overall_status":"RECRUITING","enrollment_count":198,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT02001623","title":"Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":195,"lead_sponsor_name":"Seagen Inc.","has_results":true},{"nct_id":"NCT05743517","title":"Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)","phase":"NA","overall_status":"RECRUITING","enrollment_count":192,"lead_sponsor_name":"Northwestern University","has_results":false},{"nct_id":"NCT05059782","title":"Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer","phase":"NA","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Xi'an Jiaotong University","has_results":false},{"nct_id":"NCT03593681","title":"Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy","phase":"","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Boston Scientific Corporation","has_results":true},{"nct_id":"NCT04205227","title":"ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":137,"lead_sponsor_name":"ENB Therapeutics, Inc","has_results":false},{"nct_id":"NCT03748186","title":"Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":136,"lead_sponsor_name":"Sutro Biopharma, Inc.","has_results":false},{"nct_id":"NCT03371693","title":"Cytoreductive Surgery(CRS) Plus Hyperthermic Intraperitoneal Chemotherapy(HIPEC) With Lobaplatin in Advanced and Recurrent Epithelial Ovarian Cancer","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":112,"lead_sponsor_name":"Zhongnan Hospital","has_results":false},{"nct_id":"NCT05187338","title":"Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Second Affiliated Hospital of Guangzhou Medical University","has_results":false},{"nct_id":"NCT05252390","title":"NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":82,"lead_sponsor_name":"Nuvation Bio Inc.","has_results":false},{"nct_id":"NCT03740984","title":"Effects of Music or Hypnotherapy on Cancer Patients During Chemotherapy","phase":"NA","overall_status":"TERMINATED","enrollment_count":81,"lead_sponsor_name":"Dr. Horst Schmidt Klinik GmbH","has_results":false},{"nct_id":"NCT06599749","title":"Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Advanced and Metastatic High-Grade Adenocarcinoma of Ovarian, Tubal or Peritoneal Origin (TUPRO-Gyn)","phase":"","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"University Hospital, Basel, Switzerland","has_results":false},{"nct_id":"NCT05080556","title":"Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT06161272","title":"Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Guangxi Medical University","has_results":false},{"nct_id":"NCT05001282","title":"A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":79,"lead_sponsor_name":"Elucida Oncology","has_results":false},{"nct_id":"NCT05246462","title":"The Effect of Logotherapy on Mental Health in Gynecological Cancer Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"Akdeniz University","has_results":false},{"nct_id":"NCT06662435","title":"GYNecologic Cancer-Related COGnitive Impairment","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Northwestern University","has_results":false},{"nct_id":"NCT05446298","title":"ONC-392 and Pembrolizumab in Platinum Resistant Ovarian Cancer","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":58,"lead_sponsor_name":"OncoC4, Inc.","has_results":false},{"nct_id":"NCT05200364","title":"A Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":58,"lead_sponsor_name":"Sutro Biopharma, Inc.","has_results":false},{"nct_id":"NCT06161233","title":"Pilot Study of the eHealth Application \"Cancer Patients Better Life Experience\" (CAPABLE) - Italy","phase":"NA","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"Istituti Clinici Scientifici Maugeri SpA","has_results":false},{"nct_id":"NCT05887609","title":"An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":53,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT06063070","title":"First-line Maintenance Treatment With Fluzoparib Plus Bevacizumab in Advanced BRCA Wild Type Ovarian Cancer","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":44,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT05081765","title":"The Effect of Glucose Level and Diabetes Mellitus on Ctrough of Olaparib","phase":"","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Poznan University of Medical Sciences","has_results":false},{"nct_id":"NCT06540729","title":"RC48 in Combination With AK104 and Bevacizumab in OCCC","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":39,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false},{"nct_id":"NCT03384511","title":"The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"Shandong Cancer Hospital and Institute","has_results":false},{"nct_id":"NCT05429970","title":"A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)","phase":"NA","overall_status":"RECRUITING","enrollment_count":35,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT02552121","title":"Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Seagen Inc.","has_results":true},{"nct_id":"NCT04898842","title":"Feasibility Study of a 4 Stage Bowel Obstruction Cancer Diet","phase":"NA","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Royal Surrey County Hospital NHS Foundation Trust","has_results":false},{"nct_id":"NCT07084168","title":"Multimedia Aid for Genetic Testing in Gynecologic Oncology","phase":"NA","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"UNC Lineberger Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT06964009","title":"DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Elizabeth Stover, MD, PhD","has_results":false},{"nct_id":"NCT02432378","title":"Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC Vaccines","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":25,"lead_sponsor_name":"Roswell Park Cancer Institute","has_results":false},{"nct_id":"NCT03199586","title":"Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":23,"lead_sponsor_name":"Novita Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT07096583","title":"An Exploratory Study on NK Cell-assisted Prevention of Bone Marrow Suppression During Chemotherapy for Ovarian Cancer","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":20,"lead_sponsor_name":"Anhui Provincial Cancer Hospital","has_results":false},{"nct_id":"NCT06321484","title":"Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":18,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT05858736","title":"Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":18,"lead_sponsor_name":"OncoC4, Inc.","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}